Clinical trial Recruiting at 2 sites Observational Ages 13 and up

National Highly Specialized Care for Severe Self-Harm and Eating Disorders in Swedish Youth

Official title: National Highly Specialized Care (NHV) for Children and Adolescents With Severe Self-Harm and Eating Disorders: Evaluation of Treatment Experiences, Feasibility, and Clinical Outcomes

Run by Karolinska Institutet · NCT07898059 · Data updated 2026-11-12

This observational study tests how well NHV, a highly specialized care program, works for children and teens with severe self-harm or eating disorders by asking patients and their parents about their experiences and what changes they notice.

More Eating Disorders trials

Quick facts

Study typeObservational
Ages13 Years and up
SexAll
Enrollment120 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations2 sites (Stockholm and 1 other locations)
StatusRecruiting
StartedMay 4, 2026
Main results expectedMay 31, 2030
Study endsMay 31, 2030
Registry record updatedOctober 27, 2026
Trial IDNCT07898059 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 13–17 receiving NHV for severe self-harm or severe eating disorders at BUP Stockholm or SCÄ, with parental/guardian participation and informed consent.

Probably not a fit

Patients with acute medical or psychiatric stabilization needs or language barriers preventing questionnaire completion may not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, observational study evaluates National Highly Specialized Care (NHV) provided at two Stockholm services for youths with severe self-harm or eating disorders. It uses qualitative interviews at treatment completion and one year later to capture patient and parent experiences, alongside secondary measures of feasibility, adherence, and changes in symptoms and functioning. NHV typically involves 12–13 weeks of intensive inpatient and psychotherapeutic treatment tailored by multidisciplinary teams, with approaches like DBT, FBT, or CBT as clinically appropriate. Data are collected during routine clinical care rather than mandated by the research protocol, focusing on real-world outcomes and experiences. The study aims to identify barriers to successful treatment and how NHV can facilitate transition to less intensive care when possible.

Why it matters

Potential benefit: If successful, NHV could improve patient experiences and functional outcomes for youths with severe self-harm or eating disorders and guide more effective, tailored care transitions.

How similar studies have gone: Previous work on NHV-like highly specialized care suggests potential benefits, but this exact approach in this setting is novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children and adolescents aged 13-17 years who meet the eligibility criteria for and are receiving National Highly Specialized Care (NHV) for severe self-harm or eating disorders at one of the participating clinical units.
* Parents or legal guardians of children and adolescents receiving NHV at the participating clinical units.
* Informed consent to study participation, according to applicable procedures.

Exclusion Criteria:

* Acute medical or psychiatric conditions requiring immediate healthcare interventions that temporarily preclude study participation.
* Inability to independently complete study questionnaires, for example due to language-related difficulties.

Where it's running

  • Stockholm's child and adolescent psychiatry (BUP Stockholm)
    Stockholm, Sweden
    Recruiting
  • Stockholm Centre for Eating Disorders (SCÄ)
    Stockholm, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.